Screener
Quince Therapeutics, Inc. QNCX Q2 2026 earnings
Reported August 14, 2026 · Before market open
EPS-$12.31Beat by $15.71
EPS estimate-$28.02
Next report
Nov 11, 2026 (in 2 months)EPS estimate-$4.03
Versus estimates
Diluted EPS
FAQ
- When did Quince Therapeutics, Inc. report Q2 2026 earnings?
- Quince Therapeutics, Inc. (QNCX) reported Q2 2026 earnings on August 14, 2026 before market open.
- What were Quince Therapeutics, Inc.'s Q2 2026 revenue and EPS?
- Quince Therapeutics, Inc. reported eps of $-12.31 for Q2 2026.
- Did Quince Therapeutics, Inc. beat estimates in Q2 2026?
- EPS beat the consensus estimate of $-28.02 by $15.71.
- How did Quince Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps declined 3520.6% from $-0.34.
- Where can I find Quince Therapeutics, Inc.'s Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001193125-26-350568) and the 10-Q periodic report (0001193125-26-352201) directly on SEC EDGAR. The filing index links above go to sec.gov.
